Maggie C.U. Cheang - Concepedia

Author

Maggie C.U. Cheang

Also Known As

Bernard, P. S., Berry, Donald A., Bliss, J, Carrasco, E., Cheang, Maggie, Cheang, Maggie Chon U, Cowan, David, Donald A. Berry, Díaz Rubio, Eduardo, Elena López-Knowles

467

Publications

33.6K

Citations

H-Index

Concepts

All Affiliations

BC Cancer Agency University of British Columbia Institute of Cancer Research University of North Carolina at Chapel Hill Vancouver General Hospital

About

Maggie C.U. Cheang is an author at BC Cancer Agency specializing in medicine, breast cancer, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	29	38	5.2K
2	Health Sciences	7	7	1.4K
3	Engineering	6	6	514
4	Biostatistics	3	3	242
5	Natural Sciences	1	1	15

Maggie C.U. Cheang

Publications

30.6K

Citations

H-Index

Page 1

	Year	Citations
Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes Joel S. Parker, Michael E. Mullins, Maggie C.U. Cheang, Journal of Clinical Oncology	2009	4.7K
Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study Lisa A. Carey, Charles M. Perou, Chad Livasy, JAMA	2006	3.8K
Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma Torsten O. Nielsen, Forrest D. Hsu, Kristin C. Jensen, Clinical Cancer Research	2004	2.6K
Metastatic Behavior of Breast Cancer Subtypes Hagen F. Kennecke, Rinat Yerushalmi, Ryan Woods, Journal of Clinical Oncology	2010	2.2K
Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer Maggie C.U. Cheang, Stephen Chia, David Voduc, JNCI Journal of the National Cancer Institute	2009	2.2K
Breast Cancer Subtypes and the Risk of Local and Regional Relapse K. David Voduc, Maggie C.U. Cheang, Scott Tyldesley, Journal of Clinical Oncology	2010	1.2K
Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype Maggie C.U. Cheang, David Voduc, Chris Bajdik, Clinical Cancer Research	2008	1.2K
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer Isaac García-Murillas, Gaia Schiavon, Britta Weigelt, Science Translational Medicine Breast OncologyCancer PathologyPathologyTumor BiologyOncology	2015	1.1K
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial Andrew Tutt, Holly Tovey, Maggie C.U. Cheang, Nature Medicine Tnt TrialBreast OncologyMedicinePathologyBreast Cancer	2018	862
A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor–Positive Breast Cancer Torsten O. Nielsen, Joel S. Parker, Samuel Leung, Clinical Cancer Research	2010	804

Page 1